About Incyclix Bio
Incyclix Bio is a private company based in Durham, North Carolina. It has reported $26,202,907 raised in two offerings on Form D since March 2022.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Aug 6, 2025 | Aug 22, 2025 | $11,249,977of $20.0M target | 4 | $2.8M | EquityRule 506(b) | Form D ↗ |
| Feb 22, 2022 | Mar 31, 2022amended Jul 6, 2023 | $14,952,930of $29.9M target | 5 | $2.9M | Equity, OptionsRule 506(b) | Form D/A ↗1 earlier filing |
| Total, two offerings | $26,202,907 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Incyclix Bio's Form D filed Aug 22, 2025.
NS
Norman Sharpless
Member of the Board of Managers
FE
Fredric Eshelman
Executive officer and director
PR
Patrick Roberts
Executive officer and director
Earlier filings also listed Sid Subramony (member of the board of managers, last listed Jul 2023).